Joan M. Bathon, MD

Overview
Areas of Expertise / Conditions Treated
Academic Appointments
- Professor of Medicine
Administrative Titles
- Director, Division of Rheumatology
Dr. Bathon is the Director of the Division of Rheumatology at NewYork-Presbyterian Hospital/Columbia University Medical Center and Professor of Medicine at Columbia University College of Physicians and Surgeons. Previously, she was Deputy Director of the Division of Rheumatology and Director of the Arthritis Center at Johns Hopkins. Dr. Bathon is the Editor-in-Chief of the American College of Rheumatology journal, Arthritis and Rheumatism.
Hospital Affiliations
- NewYork-Presbyterian/Columbia
Gender
- Female
Schedule an Appointment
Phone Appointments
Location(s)
Insurance Accepted
Aetna
- EPO
- HMO
- Medicare Managed Care
- NY Signature
- NYP Employee Plan
- POS
- PPO
- Signature Administrators
- Student Health
AgeWell
- Medicare Managed Care
- Special Needs Plan
Capital District Physician Health Plan
- Capital District Physician Health Plan
Cigna
- EPO
- Great West
- HMO
- POS
- PPO
Empire Blue Cross Blue Shield
- EPO
- HMO
- Medicare Managed Care
- POS
- PPO
Local 1199
- Local 1199
MagnaCare
- MagnaCare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Oxford Health Plans
- Freedom
- Liberty
- Medicare Managed Care
UnitedHealthcare
- Columbia University Employee Plan
- HMO
- Medicare Managed Care
- POS
- PPO
Credentials & Experience
Education & Training
- University of Maryland School of Medicine
- Internship: University of Maryland Medical Center
- Residency: University of Maryland Medical Center
- Fellowship: Johns Hopkins Hopital
Board Certifications
- Rheumatology
- Internal Medicine
Research
Dr. Bathon’s career has focused on understanding the pathogenesis and functional consequences of inflammation in Rheumatoid Arthritis (RA). Her group is particularly interested in understanding the effects of chronic rheumatoid inflammation on the extra-articular clinical phenotype of RA, as manifested by accelerated atherosclerosis and myocardial dysfunction. They have taken a combined epidemiological/ translational approach to address these questions, by establishing and following two RA cohorts over a prolonged period of time, and by combining sensitive imaging techniques with biomarker studies and clinical outcome assessments. In these studies they have comprehensively phenotyped the vascular beds (coronary, carotid, peripheral) of RA patients compared to controls, and identified risk factors for atherosclerosis and its progression. Current work focuses on defining prevalence and risk factors associated with vascular (aortic) inflammation, as well as myocardial inflammation, using state-of-the-art cardiac PET/CT scanning. Dr. Bathon is the PI on a longstanding R01 and co-PI on a current U01, and PI on several foundation grants. In addition, she has been the PI or co-investigator on many pivotal RA clinical trials, both industry and NIH sponsored. Dr. Bathon has authored over 160 manuscripts and book chapters. She served as Editor-in-Chief of Arthritis and Rheumatology from 2010-15. She is a standing member of the NIH-NIAMS Arthritis Musculoskeletal and Skin Diseases Clinical Trial Review Committee (AMSCT) study section, and has served on a variety of other NIH and foundation grant review study sections and as chair or member of several NIH sponsored DSMBs. She was a member of the Board of Directors of the American College of Rheumatology (ACR), and she is a past member of the FDA Arthritis Advisory Committee.
Grants
IDENTIFICATION OF IMMUNOLOGICAL MECHANISMS TARGETING THE MYOCARDIUM IN RHEUMATOID ARTHRITIS (Private)
Jul 1 2019 - Jun 30 2022
INFLAMMATION AND CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS (Federal Gov)
Jun 1 2017 - May 31 2022
EARLY IMMUNE EVENTS ASSOCIATED WITH VASCULAR INFLAMMATION IN RHEUMATOID ARTHRITIS (Private)
Aug 8 2018 - Aug 7 2020
BIOMARKERS CONSORTIUM TREATMENTS AGAINST RA AND EFFECT ON FDG PET-CT (TARGET BIOMARKER STUDY) (Private)
Sep 1 2017 - Aug 31 2018
PREDICTORS OF PROGRESSION OF ATHEROSCLEROSIS IN RA (Private)
Jul 1 2015 - Jun 30 2017
EVOLVING ADAPTIVE AND EFFECTOR MECHANISMS FROM PRE-RA THROUGH ESTABLISHED DISEASE (Federal Gov)
Jun 1 2016 - May 31 2017
TREATMENTS AGAINST RA AND EFFECT ON FDG PET/CT: THE TARGET TRIAL (Federal Gov)
Sep 28 2015 - Jun 30 2016
RHEUMATOID ARTHRITIS SYNOVIAL TISSUE NETWORK (REASON) (Federal Gov)
Sep 26 2014 - Aug 31 2015
PATHWAYS AND BIOMARKERS OF MYOCARDIAL DYSFUNCTION IN RHEUMATOID ARTHRITIS (Private)
Jul 1 2013 - Jun 30 2015
EDITORIAL AGREEMENT WITH ACR TO SERVE AS EDITOR OF ARTHRITIS & RHEUMATISM (THE JOURNAL ) (Private)
Oct 1 2010 - Jun 30 2015
TREAT TO TARGET TO REDUCE ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS (Federal Gov)
Apr 1 2013 - Mar 31 2015
BIOMARKERS OF ENHANCED CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS (Private)
Oct 1 2010 - Jun 30 2014
THE OMERAC RA BIODAM STUDY: PROSPECTIVE VALIDATION OF SOLUBL E BIOMARKERS AS PREDICTORS OF SRUCTURAL DAMAGE IN RHEUMATOID (Private)
Nov 10 2011 - Oct 31 2013
RA-ASSOCIATED LUNG DISEASE: USING QUANTITATIVE (Private)
Oct 1 2010 - Jun 30 2013
MECHANISMS OF MYOCARDIAL DYSFUNCTION IN RHEUMATOID ARTHRITIS (Private)
Dec 1 2010 - Jun 30 2012
For a complete list of publications, please visit PubMed.gov